share_log

Burning Rock Biotech Q4 EPS $(0.22) Up From $(0.31) YoY, Sales $17.10M Down From $20.62M YoY

Burning Rock Biotech Q4 EPS $(0.22) Up From $(0.31) YoY, Sales $17.10M Down From $20.62M YoY

Burning Rock Biotech第四季度每股收益爲0.22美元，高於同比0.31美元，銷售額爲1710萬美元，低於同比2,062萬美元
Benzinga ·  03/29 05:23

Burning Rock Biotech (NASDAQ:BNR) reported quarterly losses of $(0.22) per share. This is a 29.03 percent increase over losses of $(0.31) per share from the same period last year. The company reported $17.10 million in sales this quarter. This is a 17.08 percent decrease over sales of $20.62 million the same period last year.

Burning Rock Biotech（納斯達克股票代碼：BNR）公佈的季度虧損爲每股0.22美元。與去年同期每股虧損0.31美元（0.31）相比，增長了29.03％。該公司報告本季度銷售額爲1710萬美元。這比去年同期的2,062萬美元的銷售額下降了17.08％。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論